Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

J App Pharm Sci. 2020; 10(6): 123-125


AZILSARTAN CAUSING METABOLIC ENCEPHALOPATHY

Anujith G. Sekhar, Ajit Singh, Sheetal Chauhan, Kanav Khera, Tom Devasia.




Abstract
Cited by 1 Articles

Angiotensin II receptor blockers (ARBs) are the antihypertensive drugs associated with side effects, majorly like cough and electrolyte disturbance. Azilsartan is a newly marketed ARB in India, not even having well established adverse effects profile. Here we present a 58-year-old female who was admitted to the emergency department showing signs and symptoms of delirium, disorientation and vomiting for four days. The patient is known to have coronary artery disease (CAD) for that she underwent coronary artery bypass grafting (CABG). She was recently started on azilsartan for her chronic hypertension along with other drugs. The presence of electrolyte imbalance in laboratory reports and current symptoms suggested of azilsartan induced encephalopathy. The patient was recovered after discontinuation of azilsartan. This case enlightens the clinical characteristics, possible mechanism and treatment strategy opted to correct the condition.

Key words: Angiotensin II receptor blocker, Hyperkalemia, Hyponatremia, Hypertension, Renin-angiotensin-aldosterone-system






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.